Knowledge of and interest in opioid overdose education and naloxone distribution among US veterans on chronic opioids for addiction or pain

Drugs: Education, Prevention and Policy

Volumn 23, Issue 4, 2016, Pages 322-327

  Tiffany, Elizabeth ^a   Wilder, Christine M ^a,b   Miller, Shannon C ^a,b   Winhusen, Theresa ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Education; harm reduction; methadone; naloxone; opiate; opiate use; opiates; risk

Indexed keywords

EID: 84949237192     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687637.2015.1106442     Document Type: Article

References (42)

1. C.Baca, & K.Grant,. (2007). What heroin users tell us about overdose. Journal of Addictive Diseases, 26, 63–68
2. E.Barton, C.Colwell, T.Wolfe, D.Fosnocht, C.Gravitz, T.Bryan,… J.Bailey,. (2005). Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. Journal of Emergency Medicine, 29, 265–271
3. E.Barton, J.Ramos, C.Colwell, J.Benson, J.Baily, & W.Dunn,. (2002). Intranasal administration of naloxone by paramedics. Prehospital Emergency Care, 6, 54–58
4. A.S.Bennett, A.Bell, L.Tomedi, E.G.Hulsey, & A.H.Kral,. (2011). Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. Journal of Urban Health, 88, 1020–1030
5. A.Bohnert, M.A.Ilgen, J.A.Trafton, R.D.Kerns, A.Eisenberg, D.Ganoczy, & F.C.Blow,. (2014). Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clinical Journal of Pain, 30, 605–612
6. A.Bohnert, M.Valenstein, M.J.Bair, D.Ganoczy, J.F.McCarthy, M.A.Ilgen, & F.C.Blow,. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305, 1315–1321
7. E.W.Boyer,. (2012). Management of opioid analgesic overdose. New England Journal of Medicine, 367, 146–155
8. I.Buajordet, A.Naess, D.Jacobsen, & O.Brørs. (2004). Adverse events after naloxone tratment of episodes of suspected acute opioid overdose. European Journal of Emergency Medicine, 11, 19–23
9. K.Bush, D.Kivlahan, M.McDonell, S.Fihn, & K.Bradley,. (1998). The AUDIT alcohol consumption questions (AUDIT-C):An effective brief screening test for problem drinking. Archives of Internal Medicine, 158, 1789–1795
10. F.W.Brason, C.Roe, & N.Dasgupta,. (2013). Project Lazarus:An innovative community response to prescription drug overdose. North Carolina Medical Journal, 74, 259–261
11. M.T.Brugal, G.Barrio, L.F.L.De, E.Regidor, L.Royuela, & J.M.Suelves,. (2002). Factors associated with non-fatal heroin overdose:Assessing the effect of frequency and route of heroin administration. Addiction, 97, 319–327
12. Centers for Disease Control and Prevention. (2011). Vital signs:Overdoses of prescription opioid pain relievers – United States, 1999–2008. Morbidity & Mortality Weekly Report, 60, 1487–1492
13. Centers for Disease Control and Prevention. (2012a). Opioid overdoses in the United States. Journal of Pain & Palliative Care Pharmacotherapy, 26, 44–47
14. Centers for Disease Control and Prevention. (2012b). Community-based opioid overdose prevention programs providing naloxone – United States, 2010. Morbidity & Mortality Weekly Report, 61, 101–105
15. Centers for Disease Control and Prevention. (2013). National Center for Injury Prevention and Control:Data and statistics web-based injury statistics query and reporting system 2005. Retrieved October 20, 2014, from http://www.cdc.gov/injury/wisqars/LeadingCauses.html
16. Clark, A., Wilder, C., & Winstanley, E. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine, 8, 153–163
17. S.Clarke, P.Dargan, & A.Jones,. (2005). Naloxone in opioid poisoning:Walking the tightrope. Emergency Medicine Journal, 22, 612–616
18. P.O.Coffin, M.Tracy, A.Bucciarelli, D.Ompad, D.Vlahov, & S.Galea,. (2007). Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine, 14, 616–623
19. A.Dahan, L.Aarts, & T.W.Smith,. (2010). Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology, 112, 226–238
20. S.Darke, J.Ross, & W.Hall,. (1996). Overdose among heroin users in Sydney, Australia:I. Prevalence and correlates of non-fatal overdose. Addiction, 91, 405–411
21. C.Davis, D.Webb, & S.Burris,. (2013). Changing law from barrier to facilitator of opioid overdose prevention. Journal of Law, Medicine & Ethics, 41, 33–36
22. P.Dietze, D.Jolley, C.Fry, & G.Bammer,. (2005). Transient changes in behaviour lead to heroin overdose:Results from a case-crossover study of non-fatal overdose. Addiction, 100, 636–642
23. K.M.Dunn, K.W.Saunders, C.M.Rutter, C.J.Banta-Green, J.O.Merrill, & M.D.Sullivan,. (2010). Opioid prescriptions for chronic pain and overdose:A cohort study. Annals of Internal Medicine, 152, 85–92. doi:http://dx.doi.org/10.1059/0003-4819-152-2-201001190-00006
24. European Monitoring Centre for Drugs and Drug Addiction. (2015). Preventing fatal overdoses:A systematic review of the effectiveness of take-home naloxone. EMDDA Papers. Luxembourg:Publications Office of the European Union
25. Grieco, E.M., & Cassidy, R.C. (2001). Overview of race and Hispanic origin:Census 2000 brief. Retrieved from http://www.census.gov/prod/2001pubs/c2kbr01-1.pdf
26. A.J.Hall, J.E.Logan, R.L.Toblin, J.A.Kaplan, J.C.Kraner, & D.Bixler,. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300, 2613–2620. doi:http://dx.doi.org/10.1001/jama.2008.802
27. A.Kelly, D.Kerr, P.Dietze, I.Patrick, T.Walker, & Z.Koutsogiannis,. (2005). Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. The Medical Journal of Australia, 182, 24–27
28. D.Kerr, A.Kelly, P.Dietze, D.Jolley, & B.Barger,. (2009). Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction, 104, 2067–2074
29. T.Lagu, B.Anderson, & M.Stein,. (2006). Overdoses among friends:Drug users are willing to administer naloxone to others. Journal of Substance Abuse Treatment, 30, 129–133
30. National Center for Veterans Analysis and Statistics. (2013). Selected Veteran’s Health Administration Characteristics:FY2002 to FY2013. Retrieved June 14, 2015, from http://www.va.gov/vetdata/utilization.asp on
31. National Treatment Agency for Substance Misuse. (2011). The NTA overdose and naloxone training programme for families and carers. August 2011
32. L.J.Paulozzi, D.S.Budnitz, & Y.Xi,. (2006). Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology & Drug Safety, 15, 618–627
33. K.Seal, A.Kral, L.Gee, L.Moore, R.Bluthenthal, J.Lorvick, & B.Edlin,. (2001). Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area. American Journal of Public Health, 91, 1842–1846
34. K.Seal, A.Kral, S.Singleton-Banks, J.Hammond, J.Lorvick, D.Ciccarone, & B.Edlin,. (2003). Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose:A survey of street-recruited injectors in San Francisco Bay Area. Journal of Urban Health:Bulletin of the New York Academy of Medicine, 80, 291–301
35. K.A.Sporer, & A.H.Kral. (2007). Presciption naloxone:A novel approach to heroin overdose prevention. Annals of Emergency Medicine, 49, 172–177
36. M.A.Stoove, P.M.Dietze, & D.Jolley,. (2009). Overdose deaths following previous non-fatal heroin overdose:Record linkage of ambulance attendance and death registry data. Drug & Alcohol Review, 28, 347–352
37. Strang, J., Manning, V., Mayet, S., Best, D., Titherington, E., Santana, L., … Semmler, C. (2008). Overdose Training and Take-home naloxone for opiate users:Prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction, 103, 1648 1657
38. J.Strang, B.Powis, D.Best, L.Vingoe, P.Griffiths, C.Taylor, & M.Gossop,. (1999). Preventing opiate overdose fatalities with take-home naloxone:Prelaunch study of possible impact and acceptibility. Addiction, 94, 199–204
39. A.Y.Walley, Z.Xuan, H.H.Hackman, E.Quinn, M.Doe-Simkins, A.Sorensen-Alawad, … A.Ozonoff,. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts:Interrupted time series analysis. BMJ, 346, f174
40. J.Weber, K.Tataris, J.Hoffman, S.Aks, & M.Mycyk,. (2012). Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose? Prehospital Emergency Care, 16, 289–292
41. C.M.Wilder, F.W.Brason, A.K.Clark, M.D.Galanter, A.Y.Walley, & E.L.Winstanley,. (2014). Development and implementation of an opioid overdose prevention program winthin a preexisting substance use disorderstreatment center. Journal of Addiction Medicine, 8, 164–169
42. E.Yudko, O.Lozhkina, & A.Fouts,. (2007). A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal of Substance Abuse Treatment, 32, 189–198